Status:
ENROLLING_BY_INVITATION
EnCoRe MoMS: Engaging Communities to Reduce Morbidity From Maternal Sepsis (Aim 2)
Lead Sponsor:
Columbia University
Collaborating Sponsors:
Northern Manhattan Perinatal Partnership
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions:
Maternal Sepsis
Infections
Eligibility:
FEMALE
18+ years
Brief Summary
Sepsis is the second leading cause of maternal death in the U.S. For racial and ethnic minoritized birthing people, especially those who are Black, living in poverty, and from underserved communities,...
Detailed Description
Maternal sepsis is the second leading cause of maternal death, major cause of morbidity, and preventable in most cases. EnCoRe MoMS: Engaging Communities to Reduce Morbidity from Maternal Sepsis will ...
Eligibility Criteria
Inclusion
- Be 18 years or older
- Delivery admission (and) postpartum readmission at one of the Perinatal Research Consortium sites 2014-2021
Exclusion
- Under 18 years old
- Delivery admission (and) postpartum readmission at hospital that is not in the Perinatal Research Consortium
- Delivery admission before 2014 or after 2021
Key Trial Info
Start Date :
April 26 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2026
Estimated Enrollment :
400000 Patients enrolled
Trial Details
Trial ID
NCT06148532
Start Date
April 26 2023
End Date
September 30 2026
Last Update
December 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia Unviersity Medical Center
New York, New York, United States, 10032